Somerset County, Maine Rejects Prevention Funding to Protect Zero-Death Jail Treatment Program

Somerset County Commissioners in rural Maine faced an impossible choice this week: fund upstream substance use prevention services for 9,000 residents, or protect a three-year-old jail treatment program that hasn't lost a single participant to overdose after release.

They chose the jail.

On Wednesday, the Board of Commissioners rejected Kennebec Behavioral Health's request for $163,000 in opioid settlement funds to establish primary prevention programs—educational services, patient screening systems, and early intervention efforts designed to stop addiction before it starts. The decision wasn't driven by skepticism about prevention's value, but by stark arithmetic: Somerset County's entire settlement fund totals roughly $650,000, with future annual payments averaging just $150,000. Nearly all of it is already spoken for.

A Program That Works

The program consuming those dollars is Somerset County Jail's Sublocade initiative, which administers monthly injections of extended-release buprenorphine to inmates with opioid use disorder before their release. The medication, which costs approximately $1 million annually to operate, creates a pharmacological buffer during the highest-risk window for fatal overdose—the days and weeks immediately after leaving custody, when physiological tolerance has dropped but behavioral patterns often resume.

Since launching three years ago with grant funding and settlement dollars, the program has achieved what Sheriff Dale Lancaster calls an "unheard of" outcome: zero overdose deaths among released participants who received the injection. That perfect record stands in sharp relief against national data showing formerly incarcerated people face overdose mortality rates 40 times higher than the general population in the two weeks following release.

Lancaster switched from daily oral Suboxone to monthly Sublocade specifically to address the post-release treatment gap. Oral buprenorphine requires ongoing prescriptions, insurance coverage, and provider access—barriers that often prove insurmountable in rural Maine, where addiction medicine specialists are scarce and transportation to clinics requires traveling 30 or 40 miles. A single Sublocade injection, administered days before release, delivers medication for approximately 30 days, buying critical time for individuals to stabilize housing, secure insurance, and connect with community treatment.

The medication also eliminated illicit activity around Suboxone inside the jail, Lancaster noted, a persistent problem in facilities where oral formulations can be diverted or misused.

The Funding Crisis

But the program's remarkable success now faces an existential funding threat. The grants that initially supported it are expiring—Finance Director Patrick Dolan described them as "drying up"—and the county has approximately $390,000 in remaining grant funds. Combined with the $650,000 in settlement money, that provides roughly one more year of operating budget.

Lancaster is pursuing additional grants and waiting on Maine's application for a federal Medicaid waiver that would allow incarcerated individuals to use MaineCare benefits for medication-assisted treatment. Under current federal rules, people lose Medicaid eligibility upon incarceration, meaning jails must self-fund all treatment programs. State officials have warned the waiver approval process could take years, and there's no guarantee the Centers for Medicare & Medicaid Services will grant the request.

That uncertainty led commissioners to prioritize Sublocade over Kennebec Behavioral Health's proposal, despite recognizing the value of prevention. Board Chairman Robert Sezak warned that if opioid settlement funds weren't earmarked for the jail program, taxpayers could end up footing the $1 million annual bill through general revenues—a political non-starter in a rural county already stretched thin.

The Case for Prevention

Kennebec Behavioral Health, which operates seven clinics across central Maine and serves roughly 9,000 people annually, had sought the funds to build what director Rob Rogers called a "continuum of services." The organization already provides treatment and recovery support but lacks dedicated funding for primary prevention—the educational programs, screening protocols, and early intervention systems designed to catch substance use disorders before they require intensive treatment or lead to incarceration.

"Right now, we do not have 'primary prevention' funding," Rogers told commissioners. "So, we're really looking to enhance our continuum of services."

The request totaled $163,000 for this year and a similar amount next year, after which Kennebec Behavioral Health expected to secure alternative funding streams. The organization emphasized it wasn't asking for indefinite support—just seed money to launch prevention infrastructure that could eventually sustain itself through other grants.

Commissioners acknowledged the dilemma. District 5 Commissioner Joel Stetkis suggested the board could reconsider Kennebec Behavioral Health's request if federal Medicaid funding ever materialized for Sublocade, freeing up settlement dollars. District 4 Commissioner John Alsop proposed working with county staff to develop a scaled-back prevention proposal that might fit within future budget margins.

But Finance Director Dolan's recommendation was unambiguous: continue designating all settlement funds for Sublocade until the Medicaid waiver question is resolved. If federal funding never arrives, the jail program—and its unprecedented zero-death record—would collapse without the settlement backstop.

Maine's Broader Settlement Spending Patterns

The decision reflects a broader tension playing out across Maine and the nation as opioid settlement funds trickle into communities facing decades of neglected addiction infrastructure. Somerset County expects to receive approximately $2.5 million in total settlement payments by 2028, part of Maine's $230 million share from agreements with pharmaceutical manufacturers, distributors, and retailers. Payments are front-loaded, peaking at $457,000 in 2024 and tapering to as low as $60,000 by 2038.

Statewide, Maine's municipalities and counties have spent just $3 million of the $22 million received since 2022, according to a March report to the Legislature. Ten communities haven't spent any funds at all. The slow deployment reflects the same calculation Somerset County is making: settlement dollars are finite, programs require sustained operating budgets that extend decades beyond when settlement payments end, and choosing the wrong investment could mean wasting a once-in-a-generation infusion of resources.

Somerset County has allocated $50,000 of its settlement funds to support a care coordinator from Somerset Public Health working within the sheriff's office, and provided Kennebec Behavioral Health a $6,250 grant to help clients access services, primarily for transportation. Beyond that, commissioners have been deliberately conservative, banking funds against the day when grant support for Sublocade expires.

National Recognition and Evidence

The Sublocade program gained national attention last year when the New York Times profiled the jail's approach. Sheriff Lancaster and Dr. Alane O'Connor, who helped design the program, emphasized that monthly injections fundamentally change the post-release trajectory for people with opioid use disorder. Instead of leaving custody in acute withdrawal or with a prescription that expires in days, individuals depart with 30 days of medication already in their system—enough time to navigate the bureaucratic maze of insurance enrollment, provider appointments, and prescription fills that often derail continuity of care.

Scientific studies have found extended-release buprenorphine reduces overdose risk and improves treatment retention compared to daily oral formulations, particularly in settings where structural barriers—homelessness, transportation deserts, insurance gaps—make adherence difficult. The jail's zero-death record, while based on a relatively small population over three years, aligns with that evidence base.

The Prevention Dilemma

Kennebec Behavioral Health officials didn't dispute the value of the jail program. But they argued that prevention services could reduce the number of people cycling into the criminal justice system in the first place, addressing addiction before it reaches the crisis point that leads to arrest and incarceration. Educational programs in schools, workplace screening initiatives, and improved identification of substance use in primary care settings all represent opportunities to intervene upstream.

The commissioners' rejection underscores a fundamental resource constraint in rural counties: when forced to choose between a proven treatment model with documented success and a prevention strategy with diffuse, long-term benefits, immediate life-or-death stakes tend to win.

Structural Problems with Settlement Funding

Somerset County's decision also highlights the structural problem with opioid settlement funding. Unlike federal block grants or state appropriations, settlement payments arrive with no guarantee of renewal. They're one-time infusions designed to remediate harm, not permanent revenue streams. Programs launched with settlement dollars must eventually transition to other funding sources—insurance reimbursement, Medicaid, competitive grants, or general budgets—or face shutdown when the settlement well runs dry.

Sheriff Lancaster's hope that federal Medicaid rules will change reflects a broader national conversation about correctional healthcare. The current prohibition on Medicaid coverage for incarcerated individuals dates to 1965 and was designed to prevent states from shifting healthcare costs to the federal government by institutionalizing people. But addiction medicine advocates argue the policy creates perverse incentives: jails become de facto treatment providers using local budgets, then discharge individuals into communities where treatment access is scarce, precipitating the overdose deaths that settlement funds are supposed to prevent.

Several states have applied for Section 1115 waivers allowing pre-release Medicaid enrollment and coverage for certain services during the 30 days before discharge. If approved, those waivers could transform correctional addiction treatment by making it billable rather than budget-dependent. But federal approval timelines stretch years, and the Trump administration's approach to Medicaid expansion remains uncertain.

What Comes Next

For Kennebec Behavioral Health, the rejection means continuing to serve thousands of Somerset County residents without dedicated primary prevention funding. The organization's treatment and recovery services will continue—they're funded through other streams—but the gap in preventive infrastructure persists.

For Somerset County Commissioners, the decision means another year of betting on Sublocade, knowing that if federal Medicaid support doesn't materialize and no new grants appear, they'll eventually face an even harder choice: cut a program that's saved every participant it's touched, or divert general tax revenues from roads, schools, and public safety to keep it alive.

The commissioners left the door open to revisiting Kennebec Behavioral Health's proposal if circumstances change. But the immediate message was clear: when resources are limited and lives are on the line, proven interventions take priority over preventive aspirations.

What makes Somerset County's dilemma particularly acute is that both sides are right. Prevention programs demonstrably reduce addiction rates, lower treatment costs, and prevent the cascading harms—job loss, family separation, criminal justice involvement—that accompany substance use disorders. The jail program demonstrably prevents overdose deaths at the most dangerous moment in the recovery journey. Neither is optional. Both are underfunded. And settlement dollars, no matter how large they seem in aggregate, can't fill decades of disinvestment in addiction infrastructure.

Maine's opioid overdose deaths declined 16% in 2023, the first year-over-year drop in recent memory. Whether that progress continues may depend on whether counties like Somerset can sustain the programs driving those gains—and whether federal policy changes fast enough to keep local budgets from buckling under the weight of a crisis that began with corporate malfeasance but now rests on the shoulders of rural sheriffs and county commissioners deciding which lives they can afford to save.